Phase 2 trial of concurrent 5‐fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity‐modulated radiation therapy for locally advanced head and neck cancer
Year: 2010
Type: article
Study design: Clinical Trial
Source: Cancer
DOI: 10.1002/cncr.25374
Institution: Icahn School of Medicine at Mount Sinai
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2001770895
